9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 4, 1999, Pages 802-812

  Van Rompay, Koen K A ^a   Cherrington, Julie M ^b   Marthas, Marta L ^a   Lamy, Patrick D ^b   Dailey, Peter J ^c   Canfield, Don R ^a   Tarara, Ross P ^a   Bischofberger, Norbert ^b   Pedersen, Niels C ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GILEAD SCIENCES   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TENOFOVIR; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL INFECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL RATE; VIRUS ISOLATION; VIRUS MUTANT; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

EID: 0032944788     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.4.802     Document Type: Article

References (38)

1. Banapour, B., M. L. Marthas, R. A. Ramos, B. L. Lohman, R. E. Unger, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1991. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J. Virol. 65:5798-5805.
2. Barber, A. M., A. Hizi, J. V. Maizel, and S. H. Hughes. 1990. HIV-1 reverse transcriptase: structure predictions for the polymerase domain. AIDS Res. Hum. Retroviruses 6:1061-1072.
3. Boyer, P. L., A. L. Ferris, and S. H. Hughes. 1992. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66:1031-1039.
4. Centers for Disease Control and Prevention. 1997. Update: trends in AIDS incidence - United States, 1996. Morbid. Mortal. Weekly Rep. 46:862-867.
5. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
6. Condra, J. H. 1998. Resisting resistance: maximizing the durability of antiretroviral therapy. Ann. Intern. Med. 128:951-954.
7. Dailey, P. J., M. Zamroud, R. Kelso, J. Kolberg, and M. Urdea. 1995. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected rhesus macaques using a branched DNA (bDNA) signal amplification assay, abstr. 99. In Abstracts of the 13th Annual Symposium on Nonhuman Primate Models of AIDS.
8. Dawson-Saunders, B., and R. G. Trapp. 1990. Basic and Clinical Biostatistics. Appleton & Lange. Norwalk, Conn.
9. Deeks, S. G., P. Barditch-Crovo, P. S. Lietman, A. Collier, S. Safrin, R. Coleman, K. C. Cundy, and J. O. Kahn. 1998. The safety and efficacy of PMPA prodrug monotherapy: preliminary results of a phase I/II dose-escalation study, abstr. 772. In Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections.
10. Deeks, S. G., P. Barditch-Crovo, P. S. Lietman, F. Hwang, K. C. Cundy, J. F. Rooney, N. S. Hellmann, S. Safrin, and J. Kahn. 1998. Safety, pharmacokinetics and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults. Antimicrob. Agents Chemother. 42:2380-2384.
11. Del Gobbo, V., A. Foli, J. Balzarini, E. De Clercq, E. Balestra, N. Villani, S. Marini, C. F. Perno, and R. Calio. 1991. Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models. Antivir. Res. 16:65-75.
12. Desrosiers, R. C. 1990. The simian immunodeficiency viruses. Annu. Rev. Immunol. 8:557-578.
13. Foli, A., K. M. Sogocio, B. Anderson, M. Kavlick, M. W. Saville, M. A. Wainberg, X. Gu, J. M. Cherrington, H. Mitsuya, and R. Yarchoan. 1996. In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-(2-phosphonylmethoxyethyl)adenine. Antivir. Res. 32:91-98.
14. Lohman, B. L., J. Higgins, M. L. Marthas, P. A. Marx, and N. C. Pedersen. 1991. Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29:2187-2192.
15. Maeda, Y., D. J. Venzon, and H. Mitsuya. 1998. Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance. J. Infect. Dis. 177: 1207-1213.
16. Marthas, M. L., K. K. A. Van Rompay, M. Otsyula, C. J. Miller, D. Canfield, N. C. Pedersen, and M. B. McChesney. 1995. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J. Virol. 69:4198-4205.
17. Miller, M., J. M. Cherrington, P. D. Lamy, A. S. Mulato, and K. E. Anton. 1998. Genotypic changes in HIV RT which develop during Preveon (adefovir dipivoxil) therapy do not decrease susceptibility to PMPA, abstr. 41218. In Abstracts of the 12th World AIDS Conference.
18. Mulato, A. S., P. D. Lamy, M. D. Miller, W.-X. Li, K. E. Anton, N. S. Hellmann, and J. M. Cherrington. 1998. Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy. Antimicrob. Agents Chemother. 42:1620-1628.
19. Myers, G., J. A. Berzofsky, B. Korber, R. F. Smith, and G. N. Pavlakis. 1991. Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.M.
20. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
21. Otsyula, M. G., C. J. Miller, M. L. Marthas, K. K. A. Van Rompay, J. R. Collins, N. C. Pedersen, and M. B. McChesney. 1996. Virus-induced immunosuppression is linked to rapidly fatal disease in infant rhesus macaques infected with simian immunodeficiency virus. Pediatr. Res. 39:630-635.
22. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S.-J. Fong, M. Stempein, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:446-454.
23. Richman, D. D. 1993. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents. Antimicrob. Agents Chemother. 37: 1207-1213.
24. Shafer, R. W., M. A. Winters, S. Palmer, and T. C. Merigan. 1998. Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. Ann. Intern. Med. 128:906-911.
25. Tisdale, M., T. Alnadaf, and D. Cousens. 1997. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89. Antimicrob. Agents Chemother. 41:1094-1098.
26. Tsai, C.-C., K. E. Follis, T. W. Beck, A. Sabo, R. F. Grant, N. Bischofberger, and R. E. Benveniste. 1995. Prevention of simian immunodeficiency virus infection in macaques by 9-(2-phosphonylmethoxyethyl)adenine (PMPA). Science 270:1197-1199.
27. Ussery, M. A., O. L. Wood, S. C. Kunder, M. A. Bacho, D. D. Broud, S. F. Papermaster, B. E. Hall, C. J. Nielsen, M. S. Chen, J. M. Cherrington, and P. L. Black. 1997. PMPA prevents infection of HuPBMC SCID mice by HIV-1 (late breaker). In Abstracts of the Tenth International Conference on Antiviral Research.
28. Van Rompay, K. K. A., C. J. Berardi, N. L. Aguirre, N. Bischofberger, P. S. Lielman, N. C. Pedersen, and M. L. Marthas. 1998. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS 12:F79-F83.
29. Van Rompay, K. K. A., J. M. Cherrington, M. L. Marthas, C. J. Berardi, A. S. Mulato, A. Spinner, R. P. Tarara, D. R. Canfield, S. Telm, N. Bischofberger, and N. C. Pedersen. 1996. 9-[2-(Phosphonylmethoxyethyl)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob. Agents Chemother. 40:2586-2591.
30. Van Rompay, K. K. A., et al. Unpublished data.
31. Van Rompay, K. K. A., J. L. Greenier, M. L. Marthas, M. G. Otsyula, R. P. Tarara, C. J. Miller, and N. C. Pedersen. 1997. A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques. Antimicrob. Agents Chemother. 41: 278-283.
32. Van Rompay, K. K. A., M. L. Marthas, J. D. Lifson, C. J. Berardi, G. M. Vasquez, E. Agatep, Z. A. Dehqanzada, K. C. Cundy, N. Bischofberger, and N. C. Pedersen. 1998. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res. Hum. Retroviruses 14:761-773.
33. Van Rompay, K. K. A., M. L. Marthas, R. A. Ramos, C. P. Mandell, E. K. McGowan, S. M. Joye, and N. C. Pedersen. 1992. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3′-azido-3′-deoxythymidine prevents SIV infection. Antimicrob. Agents Chemother. 36:2381-2386.
34. Van Rompay, K. K. A., M. G. Otsyula, M. L. Marthas, C. J. Miller, M. B. McChesney, and N. C. Pedersen. 1995. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob. Agents Chemother. 39:125-131.
35. Van Rompay, K. K. A., M. G. Otsyula, R. P. Tarara, D. R. Canfield, C. J. Berardi, M. B. McChesney, and M. L. Marthas. 1996. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J. Infect. Dis. 173:1327-1335.
36. Wainberg, M. A., Y. Quan, H. Salomon, and J. Cherrington. 1998. The M184V substitution in reverse transcriptase increases sensitivity of both HIV-1 and SIV to PMPA, abstr. 680. In Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections.
37. Yerly, S., A. Rakik, S. Kinloch de Loes, B. Hirschel, D. Descamps, F. Brun-Vézinet, and L. Perrin. 1998. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in sero-converters infected with zidovudine-resistant variants. J. Virol. 72:3520-3523.
38. Zídek, Z., A. Holy, and D. Franková. 1997. Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production. Eur. J. Pharmacol. 331:245-252.